SKVI — Skinvisible Balance Sheet
0.000.00%
- $1.22m
- $6.95m
- $0.02m
- 52
- 30
- 47
- 38
Annual balance sheet for Skinvisible, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.036 | 0.066 | 0.081 | 0.001 | 0.01 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.008 | 0 | 0.019 | 0.027 | 0.023 |
Prepaid Expenses | |||||
Total Current Assets | 0.05 | 0.074 | 0.11 | 0.035 | 0.042 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 0.2 | 0.227 | 0.247 | 0.163 | 0.158 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.72 | 3.06 | 3.64 | 3.51 | 3.68 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 4.66 | 5.64 | 6.89 | 9.19 | 9.4 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -4.45 | -5.42 | -6.64 | -9.02 | -9.25 |
Total Liabilities & Shareholders' Equity | 0.2 | 0.227 | 0.247 | 0.163 | 0.158 |
Total Common Shares Outstanding |